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Abstract
Background: Mammalian lipoxygenases (LOXs) are categorised
with respect to their positional specificity of arachidonic acid
oxygenation. However, the mechanistic basis for this classification
is not well understood. To gain a deeper insight into the structural
basis of LOX specificity we determined the reaction characteristics
of wild-type and mutant mammalian LOX isoforms with native
and synthetic fatty acids substrates.
Results : The rabbit 15-LOX is capable of catalysing major 12-
lipoxygenation when the volume of the substrate-binding pocket is
enlarged. These alterations in the positional specificity can be
reversed when bulky residues are introduced at the g end of the
substrate. Simultaneous derivatisation of both ends of fatty acids
forces a 15-LOX-catalysed 5-lipoxygenation and this reaction
involves an inverse head-to-tail substrate orientation. In contrast,
for arachidonic acid 5-lipoxygenation by the human 5-LOX the
substrate fatty acid may not be inversely aligned. The positional
specificity of this isoenzyme may be related to its voluminous
substrate-binding pocket. Site-directed mutagenesis, which leads
to a reduction of active site volume, converts the 5-LOX to a 15-
lipoxygenating enzyme species.
Conclusions: The positional specificity of LOXs is not an
invariant enzyme property but depends on the substrate structure
and the volume of the substrate-binding pocket. 15-LOX-
catalysed 5-lipoxygenation involves an inverse substrate alignment
but this may not be the case for 5-LOXs. Thus, both theories for
the mechanistic basis of 5-lipoxygenation (straight and inverse
substrate orientation) appear to be correct for different LOX
isoforms. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Atherosclerosis ; Eicosanoid; In£ammation;
Lipid peroxidation; Mutagenesis
1. Introduction
Lipoxygenases (LOXs) constitute a family of lipid-per-
oxidising enzymes, which catalyse the dioxygenation of
polyenoic fatty acids to their corresponding hydroperox-
ides [1,2]. Mammalian LOXs are involved in the biosyn-
thesis of mediators of anaphylactic disorders and have
been implicated in cell maturation and di¡erentiation
[1,2]. Animal LOXs are classi¢ed with respect to their
positional speci¢city of arachidonic acid oxygenation and
are referred to as 5-, 8-, 12- and 15-LOXs. Although the
mechanistic basis of LOX speci¢city is far from clear the
speci¢city-related nomenclature is generally accepted. Our
current understanding of how the positional speci¢city of
LOX isoenzymes is determined derived from crystallo-
graphic studies [3^6] and site-directed mutagenesis [7^9].
The four available LOX crystal structures suggest a U-
shaped substrate-binding cleft the bottom of which is de-
¢ned by crucial amino acids. For the rabbit 15-LOX these
amino acids are F353, I418, M419, and I593 and site-di-
rected mutagenesis of these residues led to alterations in
the positional speci¢city [7,8]. Similarly, F359, A424, N425
and A603 have been identi¢ed as sequence determinants
for the human 5-LOX [9]. The walls of the substrate-bind-
ing cleft of the rabbit 15-LOX are lined by hydrophobic
residues, except for two polar side chains, Glu357 and
Gln548, which are adjacent to the iron centre. A simple
model for substrate alignment at the active site of LOXs is
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that the hydrophobic base of the substrate-binding cage,
in concert with the charged residue at the opening of the
pocket, positions substrate fatty acids appropriately for 5-,
8-, 11-, 12- or 15-lipoxygenation [10]. For 12- and 15-
LOXs the substrate fatty acid slides into the active site
with its methyl terminus ahead [11,12]. In contrast, the
substrate alignment for arachidonic acid 5-lipoxygenation
has recently become a matter of discussion [13,14] and for
the time being there are two hypotheses rationalising the
positional speci¢city of 5-lipoxygenation. (i) The orienta-
tion theory [13]: this hypothesis suggests that for 5-lipoxy-
genation fatty acids may slide into the substrate-binding
cleft with the carboxylate group ahead. The possibility of
such an inverse substrate orientation was ¢rst concluded
during mechanistic studies on corn and soybean LOXs
[15]. More recently, an inverse substrate alignment was
suggested for 15-HETE methyl ester oxygenation by the
rabbit 15-LOX [16] and when the human epidermis-type
15-LOX was mutated to an 8S-lipoxygenating enzyme spe-
cies [17]. With this hypothesis the stereochemistry of 5-
and 8-lipoxygenation can be explained perfectly. However,
its major problem is the energetic penalty associated with
burying the polar carboxylate in the hydrophobic environ-
ment of the substrate-binding pocket [14]. In fact, for
burying a hydroxy group at the active site of LOXs an
energy barrier of 5.4 kJ/mol (soybean LOX) or 7.8 kJ/mol
(rabbit LOX) was calculated [18] and for the more polar
carboxylate the energy penalty is expected to be even high-
er. (ii) The volume theory [5,14] : according to this hypoth-
esis the substrate alignment is similar for all LOX isoforms
(methyl end slides into the active site). The positional spe-
ci¢city depends on the volume of the substrate-binding
cavity. A structural model of the active site of 12-LOXs
suggested a cavity which is about 6% larger than that of
15-LOX and 5-LOX has a 20% bigger substrate-binding
cage [14]. The major disadvantage of the volume hypoth-
esis is that the stereochemistry of arachidonate 5-lipoxyge-
nation is not straightforward. However, considering the
structural £exibility of fatty acids it appears possible that
arachidonic acid may adopt a steric conformation suitable
for pro-S hydrogen abstraction from C7.
The present study was aimed at testing the two hypoth-
eses of LOX speci¢city using two mammalian LOX iso-
forms (rabbit 15-LOX and human 5-LOX). To achieve
this goal a combination of targeted substrate modi¢cation
and site-directed mutagenesis was used and we found that
both theories may be applicable under certain experimen-
tal conditions. Thus, they may not exclude each other.
2. Results
2.1. Oxygenation of modi¢ed arachidonic acid derivatives
by the pure rabbit 15-LOX
Free polyenoic fatty acids slide into the substrate-bind-
ing pocket of 12/15-LOX with their methyl end ahead
[11,12]. For optimal binding the substrate’s hydrogen do-
Scheme 1. Substrate alignment at the active site of LOXs with di¡erent
positional speci¢city. Arachidonic acid is aligned at the active site of 15-
LOXs (singular positional speci¢city) in such a way that the bisallylic
C13 is located in close proximity to the enzyme’s hydrogen acceptor
(probably the non-haem iron). 12-LOXs (singular positional speci¢city)
have a deeper substrate-binding pocket so that the substrate may slide
in farther. Thus, the bisallylic C13 is displaced from the hydrogen accep-
tor whereas C10 approaches it favouring hydrogen abstraction from this
pro-chiral centre. LOXs with dual positional speci¢city (12/15-LOXs)
are capable of abstracting hydrogen from di¡erent bisallylic methylenes
(C10 and C13).
Fig. 1. Reaction speci¢city of the recombinant rabbit 15-LOX with ara-
chidonic acid as substrate. The recombinant rabbit reticulocyte LOX
was expressed in Escherichia coli and aliquots of the LOX-active Ni-
agarose fractions were incubated in the standard assay system (see Sec-
tion 5) for 15 min at room temperature (total assay volume 1 ml). After
reduction of the hydroperoxy products (borohydride) and acidi¢cation
to pH 3 proteins were precipitated with an equal volume of ice-cold
methanol, the debris was spun down and aliquots of the clear superna-
tant were injected to RP-HPLC with the solvent system methanol/water/
acetic acid (80:20:0.1, v/v). The chemical structure of the reaction prod-
ucts was concluded from co-injections with authentic standards and
from GC/MS of the native product and its hydrogenated derivatives. In-
set : Enantiomer composition of the two reaction products.
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nor site (bisallylic methylene) is localised in close proxim-
ity to the enzyme’s hydrogen acceptor, most probably the
non-haem iron. Thus, optimal substrate alignment re-
quires a de¢ned distance between the bisallylic methylene
and the methyl end of the substrate molecule (Scheme 1).
If this distance is short a dual positional speci¢city results
since two bisallylic methylenes are located in proximity to
the iron centre (Scheme 1). The native rabbit 15-LOX
oxygenates arachidonic acid predominantly at C15 [19]
and here we con¢rmed this ¢nding for the recombinant
enzyme (Fig. 1). The selective formation of 15S-
H(P)ETE suggests an almost optimal substrate alignment
at the active site so that a hydrogen abstraction from C10
(oxygenation at C12) may only be a minor site reaction. To
disturb this optimal alignment we modi¢ed the structure
of the fatty acid substrate in three di¡erent ways (Table 1).
(i) Introduction of more space-¢lling residues [^(CH3)3 or
J] at the methyl end of arachidonic acid. This modi¢cation
was predicted to displace the bisallylic methylene C10 from
the enzyme’s hydrogen acceptor reducing the enzyme’s
capability of 12-lipoxygenation. (ii) Replacement of the
substrate’s g-terminal CH3 group by a polar OH. An ar-
achidonic acid-like alignment of this substrate should be
hindered because of the energetic barrier associated with
burying the polar OH group in the hydrophobic environ-
ment of the substrate-binding pocket. Thus, this substrate
should be prone to an inverse orientation. (iii) Methyla-
tion of the polar carboxylate. To force an inverse substrate
orientation the energy penalty associated with burying the
polar carboxylate in the hydrophobic milieu of the sub-
strate-binding pocket should be reduced and this can be
accomplished by carboxylate methylation.
When arachidonic acid (18-CH2-CH3-C20:v5,8,11,14),
its 18-CH2-J-C19:v5,8,11,14 and its 18-CH2-C-(CH3)3-
C23:v5,8,11,14 derivatives were oxygenated by the pure
rabbit 15-LOX we observed the formation of one major
conjugated diene in reverse phase and/or straight phase
high performance liquid chromatography (RP- or SP-
HPLC) (data not shown). These products contributed
some 90% to the mixture of oxidation products for each
substrate (Table 2) and were identi¢ed as the correspond-
ing 15-hydro(pero)xy derivatives by gas chromatography/
mass spectrometry (GC/MS) (Table 3). Interestingly, we
did not detect any 12-lipoxygenation products with either
18-CH2-J-C19:v5,8,11,14 or its 18-CH2-C-(CH3)3-C23:
v5,8,11,14 derivative. These data are plausible if one con-
siders the fact that in these synthetic substrates the bisal-
lylic methylene C10 is more distant from the g end when
compared with arachidonic acid (Table 1). Substitution of
an OH group for the terminal CH3 of arachidonic acid
caused a dramatic change in the positional speci¢city of
the lipoxygenase reaction (Table 2). Using 18-CH2-OH-
C19:v5,8,11,14 as substrate we observed a major 12-lip-
oxygenation (Fig. 2). Since the distance of C10 from the g
end of this fatty acid was only slightly shorter than in
arachidonic acid we expected only a minor shift towards
12-lipoxygenation. The more drastic alterations observed
indicate that other factors such as polarity of the g residue
may also in£uence the substrate alignment at the active
site. Interestingly, we did not detect any 5-lipoxygenation
products suggesting that introduction of an g-terminal
OH group is not su⁄cient to force an inverse substrate
orientation. When g-OH arachidonic acid was used as
substrate an exclusive 15-lipoxygenation was observed
Table 1
Structures of synthetic LOX substrates
For calculations of the distances the most distant atom at the g end
was used.
Table 2
Oxygenation of arachidonate derivatives modi¢ed at the methyl termi-
nus
The various arachidonate derivatives were oxygenated by the pure rab-
bit reticulocyte 15-LOX (0.4 Wg/ml) at pH 7.4 in the standard assay sys-
tem (Section 5). Apparent KM and Vmax values were extracted from
Lineweaver^Burk plots (measurements at ¢ve di¡erent substrate concen-
trations). Vmax values are given as turnover number under Vmax condi-
tions (substrate saturation). The ratio of C12 and C15 oxygenation was
calculated from the RP- and SP-HPLC analyses. The chemical struc-
tures of the products were concluded from GC/MS data (Table 3) ob-
tained with the derivatised native and hydrogenated compounds. n.d.,
not determined because of the low reaction rate. *In addition to the 15-
lipoxygenation products about 10% of 5-lipoxygenation was observed.
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(data not shown). Since the methyl end of this substrate is
one CH2 unit longer than that of the 18-CH2-OH-
C19:v5,8,11,14 this result was actually expected.
Comparing the kinetic constants of fatty acid oxygen-
ation (Table 2) one may conclude that among the sub-
strates tested arachidonic acid is the best one. The low
KM indicates a strong binding a⁄nity and the high turn-
over rate suggests an optimal substrate alignment for C13
hydrogen abstraction (hydrogen abstraction is the rate-
limiting step of the LOX reaction). The iodine-substituted
fatty acid was oxygenated with a similar Vmax, but sub-
strate binding was less e¡ective. The highest KM was de-
termined for the g-hydroxylated fatty acid and this may
re£ect the energetic penalty associated with burying the
polar OH group in the hydrophobic milieu of the sub-
strate-binding pocket. The dicarboxylic derivative was
not oxygenated which may be due to similar energetic
constraints.
When compared with the free acid, arachidonic acid
methyl ester is less well oxygenated. Under our experimen-
tal conditions Vmax was only about 50% of that of the free
acid and the binding a⁄nity was lower by one order of
magnitude (Table 4). The pattern of reaction products was
almost identical; with both substrates 15-H(P)ETE was
identi¢ed as the major product. These data suggest that
methylation of the carboxylate did not lead to major alter-
ations in substrate alignment. In contrast, methylation of
18-CH2-OH-C19:v5,8,11,14 drastically altered the product
pattern (Fig. 2). Although the 12-oxygenation product was
still detectable (33%) the major reaction catalysed was
5-lipoxygenation (67%). Moreover, the binding a⁄nity of
the methyl ester was several-fold higher than that of the
free acid, which contrasts with the data of methyl arachi-
donate oxygenation. Although the mechanistic reasons
for this e¡ect have not been studied in detail it may be
assumed that the energetic barrier associated with burying
the methyl ester group in the hydrophobic environment
of the active site may be smaller than that for the OH
group and thus, an inverse orientation may be favoured.
When the C5NC6 double bond was removed from the
substrate molecule we did not observe any 5-lipoxygena-
tion (Table 4). This ¢nding was straightforward since lack
of the bisallylic C7 prevented this reaction. An even more
pronounced alteration in the positional speci¢city was
observed when 18-CH2-C-(CH3)3-C23:v5,8,11,14 was
Table 3
Mass spectral data of lipoxygenase products
In parentheses relative abundances in %. *CH2-J was reduced to CH3
during hydrogenation, **the free carboxylic group was ethylated with
diazoethane (numbering of the carbon atoms as for the other sub-
strates).
Fig. 2. Oxygenation products formed from 18-CH2-OH-C19:v5,8,11,14
by the native rabbit 15-LOX. The pure rabbit 15-LOX (4.2 Wg/ml) was
incubated in the standard assay (1 ml assay volume) in the presence of
100 WM 18-CH2-OH-C19:v5,8,11,14 (free acid and methyl ester). The
hydroperoxy products formed were reduced with sodium borohydride
and methylated. The samples were acidi¢ed and the proteins were pre-
cipitated with 1 ml ice-cold methanol. Debris was spun down and ali-
quots of the clear supernatant were injected to RP-HPLC (see Section
5) carried out with the solvent system methanol/water/acetic acid (70/30/
0.1, v/v). The chemical structures of the compounds were concluded
from GC/MS data obtained for the derivatised native compounds and
their hydrogenated derivatives (Table 3). Inset: The UV spectra of the
major reaction products are very similar and indicate the presence of a
conjugated diene chromophore.
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used as the substrate. Methylation of this fatty acid led to
a complete shift of the positional speci¢city from
15- towards 5-lipoxygenation (Fig. 3). With the free acid
we observed the predominant formation of the corre-
sponding 15-hydro(pero)xy derivatives (Table 4). In con-
trast, 5-lipoxygenation was the major process when the
methyl ester was used. In chiral phase HPLC both the
5- and 15-oxygenation products gave a single peak sug-
gesting a high degree of chirality (data not shown). Com-
parison of the kinetic constants for the 18-CH2-C(CH3)3-
C23:v5,8,11,14 derivatives did not reveal major di¡erences
(Table 4).
As indicated in Table 2 the dicarboxylic acid 18-HOOC-
C19:v5,8,11,14 was not oxygenated by the rabbit 15-LOX.
As a possible reason for the lacking activity energetic con-
straints associated with burying the polar carboxylate in
the hydrophobic environment of the substrate-binding
pocket were discussed. To reduce this energy barrier but
to keep a free carboxylate the dicarboxylic acid was mono-
methylated. Surprisingly, we found that the monomethyl
ester was rapidly oxygenated (16.8 s31) although its bind-
ing a⁄nity was rather low (KM = 166 WM). RP-HPLC re-
vealed a single oxygenation product and GC/MS data in-
dicated that dioxygen was introduced close to the
monomethylated carboxylate (Table 3). These data suggest
that the methylated carboxylate may penetrate into the
substrate-binding pocket and the free carboxylate is kept
outside the hydrophobic environment.
Summarising our data on the oxygenation of arachidon-
ic acid derivatives by the native rabbit 15-LOX one may
conclude that neither derivatisation of the carboxylate nor
modi¢cation of the g terminus of fatty acids may lead to
major 5-lipoxygenation. However, if both substrate ends
are modi¢ed simultaneously 5-lipoxygenation may be
forced.
2.2. Oxygenation of modi¢ed arachidonic acid derivatives
by mutant 15-lipoxygenase species
The data obtained with the synthetic arachidonate de-
rivatives indicate that 15-LOXs are capable of catalysing
5-lipoxygenation if fatty acids are suitably derivatised. It
should be stressed at this point that the 5-lipoxygenated
substrates contain a bisallylic C13 so that, in principle, 15-
lipoxygenation was possible. However, the enzyme fav-
oured 5-lipoxygenation and as a mechanistic reason for
this observation an inverse head-to-tail substrate orienta-
tion may be suggested. To test this hypothesis we mutated
the rabbit 15-LOX at critical positions and analysed the
oxygenation products formed from the substrates, which
are 5-lipoxygenated by the wild-type enzyme. The I418A
mutant of the rabbit 15-LOX oxygenates arachidonic acid
predominantly to 12-H(P)ETE [8]. Since this amino acid is
localised at the bottom of the substrate-binding pocket the
IleCAla exchange deepens the pocket so that the methyl
Table 4
E¡ects of carboxylate methylation on the oxygenation characteristics of
arachidonate derivatives by the pure reticulocyte 15-LOX
The various arachidonate derivatives were oxygenated by the rabbit re-
ticulocyte 15-LOX (0.4 Wg/ml) at pH 7.4 in the standard assay system
(see Section 5). Substrates were methylated with diazomethane and re-
puri¢ed by RP-HPLC. Apparent KM and Vmax values were extracted
from Lineweaver^Burk plots (measurements at ¢ve di¡erent substrate
concentrations). The patterns of the oxygenation products for each sub-
strate were compared by RP-HPLC after complete methylation. GC/MS
data indicating the structure of the oxygenation products are summa-
rised in Table 3. To calculate the relative kinetic parameters the appar-
ent KM for arachidonic acid (6.5. WM) was set at 1 and Vmax (22.8 s31)
was set at 100. *This substrate lacks the C5NC6 double bond, no 5-lip-
oxygenation is possible.
Fig. 3. Oxygenation products formed from 18-CH2-C(CH3)3-
C23:v5,8,11,14 by the native rabbit 15-LOX. The puri¢ed native rabbit
15-LOX (4.2 Wg/ml) was incubated in the standard assay (1 ml assay
volume) in the presence of 100 WM of 18-CH2-C(CH3)3-C23:v5,8,11,14
(free acid and methyl ester). The hydroperoxy products formed were re-
duced with sodium borohydride, the sample was acidi¢ed and the lipids
were extracted. The solvent was evaporated, the free carboxylate was
methylated, the lipids were reconstituted in 100 Wl methanol and ali-
quots were injected to RP-HPLC puri¢cation. Conjugated dienes were
collected and further analyzed by SP-HPLC with the solvent system
n-hexane/2-propanol/acetic acid (100:1:0.1, v/v). The chemical structures
of the products were concluded from GC/MS data obtained for the de-
rivatised native product and its hydrogenated derivatives (Table 3).
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terminus of the fatty acid may slide in farther approaching
the bisallylic methylene C10 to the enzymes hydrogen ac-
ceptor (Scheme 1). If one assumes an inverse substrate
orientation for the 5-lipoxygenated fatty acids the I418A
mutant should catalyse 8-lipoxygenation (Scheme 2). To
test this prediction we prepared the I418A mutant and
determined its positional speci¢city when arachidonic
acid, 18-CH2-C(CH3)3-C23:v5,8,11,14, 18-CH2-OH-C19:
v5,8,11,14 and their methyl esters were used as substrates.
For this purpose the wild-type rabbit 15-LOX and its
I418A mutant were overexpressed in Escherichia coli and
aliquots of the puri¢ed enzyme preparations (see Section
5) were used as enzyme sources. When analysing the prod-
uct pattern of arachidonic acid oxygenation we found that
the wild-type enzyme produced mainly 15-HPETE (12-/15-
HPETE ratio 4:96) whereas the mutant 15-LOX preferred
12-lipoxygenation (12-/15-HPETE ratio of 89:11). The
free acid of 18-CH2-C(CH3)3-C23:v5,8,11,14 was oxygen-
ated by the wild-type recombinant enzyme at C15 and
small amounts of the corresponding 5-hydro(pero)xy de-
rivatives were also detected (Table 5). Using the methyl-
ated substrate an exclusive 5-lipoxygenation was observed.
These data are in line with the product pattern obtained
with the native enzyme (Fig. 3). The I418A mutant con-
verted this substrate to a more complex product mixture
(Table 5) which can be explained as follows. The mutant
enzyme has a deeper substrate-binding pocket. Since the
18-CH2-C(CH3)3-C23:v5,8,11,14 substrate contains a
bulky trimethyl group at its methyl end the 15-
LOXC12-LOX conversion achieved by the mutation
was predicted to be incomplete with this substrate. In
fact, 15-lipoxygenation was identi¢ed as the major oxygen-
ation process and we only detected some 20% of 12-oxy-
genation products. The 5-hydro(pero)xy derivative, which
amounted to about one third of the oxygenation products,
may originate from an inverse head-to-tail substrate ori-
entation. To obtain experimental evidence for such an in-
verse alignment the oxygenation products of the methyl
ester were analysed. The wild-type LOX catalysed exclu-
sively 5-lipoxygenation (Table 5) and our model for an
inverse substrate alignment predicted an 8-lipoxygenation
when the I418A mutant was used as the catalyst (Scheme
2). Analysing the product pattern of 18-CH2-C(CH3)3-
C23:v5,8,11,14 methyl ester oxygenation by the I418A
mutant we did indeed detect signi¢cant amounts of 8-lip-
oxygenation products (Fig. 4).
When the recombinant wild-type 15-LOX was reacted
with 18-CH2-OH-C19:v5,8,11,14 the results were similar
to those obtained with the native enzyme. With the free
acid 12-lipoxygenation was the major process. In contrast,
the methyl ester was mainly oxygenated at C5 and this
may be due to an inverse substrate orientation. To check
for such an inverse substrate alignment we analysed the
product pattern obtained with the I418A mutant. As dis-
cussed for the 18-CH2-C(CH3)3-C23:v5,8,11,14 methyl
ester the large amounts of the corresponding 8-hydro-
(pero)xy products suggest an inverse orientation of the
substrate.
Similar results were also obtained when the free acids
and the methyl esters of 18-CH2-C(CH3)3-C23:v5,8,11,14
were oxygenated by the F353L mutant. This mutant cat-
alyses major arachidonic acid 12-lipoxygenation and we
also observed a shift from 5- towards 8-lipoxygenation
with the methyl esters as substrate.
Table 5
Composition of the product pattern formed from arachidonic acid de-
rivatives by the recombinant wild-type and mutant (I418A) rabbit 15-
LOX
Mutant and wild-type 15-LOX were expressed in E. coli and aliquots of
the puri¢ed enzyme preparations exhibiting a comparable arachidonate
oxygenase activity were used for incubations (see Section 5). The oxy-
genation products were isolated by RP-HPLC, puri¢ed by SP-HPLC
and their structures were identi¢ed by GC/MS (Table 3). Lysates ob-
tained from bacteria transformed with the wild-type plasmid did not
oxygenate any of the substrates.
Scheme 2. E¡ect of a deeper substrate-binding pocket on the oxygena-
tion speci¢city of inversely bound substrates. 15-LOX-catalysed 5-lip-
oxygenation involves an inverse head-to-tail substrate orientation. The
major consequence of an inverse substrate alignment is that the bisal-
lylic C7 is localised in close proximity to the enzyme’s hydrogen accep-
tor. Deepening of the substrate-binding pocket allows the substrate to
slide in farther so that C7 is displaced from the hydrogen acceptor
whereas C10 approaches it. Such an alignment is predicted to lead to an
increased share of 8-lipoxygenation.
CHBIOL 115 9-8-01
784 Chemistry & Biology 8/8 (2001) 779^790
2.3. Oxygenation of fatty acids by 5-LOX mutants with
altered positional speci¢city
Recently it was reported that the human 5-LOX could
be converted to a 15-lipoxygenating enzyme species when
sequence determinants of the positional speci¢city (F359,
A424, N425 and A603) were mutated to more space-¢lling
residues [9]. For this study we expressed the 15-lipoxyge-
nating quadruple mutant F359W+A424I+N425M+A602I
in E. coli and compared its reaction speci¢city with that of
the wild-type enzyme using di¡erent polyenoic fatty acids
as substrate. From Table 6 it can be seen that the C20 fatty
acids containing C5NC6 and C8NC9 double bonds were
good substrates for the wild-type enzyme. In contrast, C20
fatty acids lacking these double bonds as well as all C18
fatty acids were not oxygenated. The 15-lipoxygenating
quadruple mutant oxygenated all polyenoic fatty acids
containing C11NC12 and C14NC15 double bonds. Only
the C20 :v5,8,11 substrate, which lacks the C11NC12 dou-
ble bond was not oxygenated. These data suggest that for
both the wild-type and mutant 5-LOX, the distance of the
bisallylic methylene (site of hydrogen abstraction) from
the g end of the fatty acid may be of major importance.
The cucumber linoleate 13-LOX can be converted to a
9-lipoxygenating enzyme species by site-directed mutagen-
esis [20]. This alteration in positional speci¢city has been
Fig. 4. Oxygenation products formed from the methyl ester of 18-CH2-
C(CH3)3-C23:v5,8,11,14 by the recombinant wild-type rabbit 15-LOX
and its I418A mutant. The wild-type and mutant 15-LOX species were
expressed in E. coli. Aliquots of the puri¢ed LOX preparation (Ni-aga-
rose column) exhibiting comparable arachidonic acid oxygenase activ-
ities were incubated for 15 min at room temperature in the standard 15-
LOX assay system in the presence of 100 WM 18-CH2-C(CH3)3-
C23:v5,8,11,14 methyl ester (1 ml assay volume). The hydroperoxy
products formed were reduced with sodium borohydride, the sample
was acidi¢ed and proteins were precipitated with 1 ml ice-cold metha-
nol. Debris was spun down and aliquots of the clear supernatant were
injected to RP-HPLC carried out with solvent system methanol/water/
acetic acid (75/25/0.1, v/v). Lower inset: Key ions observed in GC/MS
and fragmentation pattern of the major oxygenation product formed by
the wild-type enzyme. Upper inset: Informative key ions obtained in
electrospray MS for the early eluting compound formed by the I418
mutant. These data indicate the structure as the corresponding 8-hy-
droxy derivatives.
Fig. 5. Oxygenation products formed from arachidonic acid by wild-
type and mutant 5-LOX (F359W+A424I+N425M+A603I). The enzyme
species were expressed in E. coli and puri¢ed on ATP Sepharose. The
active fractions were pooled and aliquots exhibiting a similar arachidon-
ic acid oxygenase activity were incubated for 5 min at room temperature
in the standard 5-LOX assay. The oxygenation products were reduced
with sodium borohydride, the samples were acidi¢ed, proteins were pre-
cipitated with 1 ml ice-cold methanol and after centrifugation aliquots
of the supernatant were injected to RP-HPLC using a solvent system of
methanol/water/acetic acid (80:20:0.1, v/v).
Table 6
Oxygenation of di¡erent substrate fatty acids by 5-LOX mutants
substrate 5-LOX F359W+A424I+N425M+A603I
C20:v5,8,11,14 100 100
C20:v5,8,11 132 0
C20:v 11,14,17 0 90
C20:v11,14 0 106
C18:v9,12 3 142
C18:v6,9,12 0 144
C18:v9,12,15 0 576
Wild-type human 5-LOX and its F359W+A424I+N425M+A603I mutant
were expressed in E. coli and puri¢ed on ATP Sepharose. Aliquots of
the enzyme preparation were incubated in the standard 5-LOX assay at
room temperature for 5 min. After reduction with sodium borohydride
and acidi¢cation 1 ml of ice-cold methanol was added and the protein
precipitate was spun down. Aliquots of the clear supernatant were ana-
lysed by RP-HPLC (see Section 5). The amount of products formed by
each mutant from arachidonic acid was set at 100 and the relative prod-
uct formation with the other substrates is given.
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suggested to be due to an inverse substrate orientation. It
was hypothesised that the mutation carried out might de-
mask a charged amino acid at the active site, which then
may interact with the substrate’s carboxylate [20]. To ¢nd
out whether the human 5-LOX is also capable of burying
a free carboxylate at its active site experiments with a
dicarboxylic fatty acid (18-HOOC-C19:v5,8,11,14) were
carried out. This substrate is a symmetric molecule (Table
2) and the distance of the bisallylic methylene C7 from
either carboxylate should be optimal for the human
5-LOX. If the enzyme is capable of burying a free carbox-
ylate at its active site the dicarboxylic acid was expected to
be a suitable substrate. However, we found that neither
the wild-type enzyme nor the 15-lipoxygenating quadruple
mutant was capable of oxygenating the dicarboxylic fatty
acid.
The ine⁄cient oxygenation of the dicarboxylic fatty acid
may be due to energetic constraints associated with bury-
ing the free carboxylate in the hydrophobic environment
of the substrate-binding pocket. If this conclusion is true
monomethylation should render the substrate oxidisable.
In fact, we found that the monomethyl ester of 18-HOOC-
C19:v5,8,11,14) was oxygenated by 5- and 15-LOXs with
a high reaction rate (Fig. 6, inset). The rabbit 15-LOX
(Fig. 6) converted this substrate predominantly to the
15-hydro(pero)xy derivatives (free carboxylate carbon is
numbered C1). The most informative ions in the negative
ion mass spectra (explanation, relative abundance in pa-
rentheses) were as follows: m/z 349.7 (M3, 2%), 317
(M33MeOH, 100%), 218.7 (K cleavage, 3%). In contrast,
the wild-type 5-LOX (Fig. 6) catalysed a major 5-lipoxy-
genation (free carboxylate carbon is numbered C1) indi-
cating that oxygen is introduced at a carbon atom which is
far distant from the methylated carboxylate. Here again
the following mass spectral data indicate the structure of
the oxygenation product: m/z 349.4 (M3, 3%), 330.9
(M33H2O, 82%), 317.1 (M33MeOH, 100%), 114.7 (K
cleavage, 16%). Since the methylated carboxylate is likely
to slide into the active site because of energetic reasons
one may conclude that a similar situation may be the case
for free arachidonic acid. These data and the inability of
the enzyme to oxygenate the free dicarboxylic acid may
suggest that 5-lipoxygenation by the human 5-LOX in-
volves a similar substrate alignment at the active site as
15-LOXs.
3. Discussion
The positional speci¢city of LOXs, which is the basis of
the currently used enzyme nomenclature, is not an abso-
lute enzyme property but depends on the alignment of the
substrate at the active site. Modi¢cation of the substrate
structure [9,11,12] and/or site-directed mutagenesis of crit-
ical amino acids [7,8,10] in£uence the substrate alignment
and thus a¡ect the speci¢city of the LOX reaction. For 12-
and 15-lipoxygenation a topological model for substrate
binding at the active site has been introduced (Scheme 1)
suggesting that substrate fatty acids slide into the hydro-
phobic substrate-binding pocket with its methyl end ahead
[21,22]. Although no direct structural data have been pub-
lished as to the substrate alignment at the active site for
any LOX isoform there is a plethora of experimental evi-
dence suggesting that for 15-lipoxygenation arachidonic
acid slides into the substrate-binding pocket with its meth-
yl end ahead so that the bisallylic methylene C13 is located
in close proximity to the enzyme’s hydrogen acceptor. This
model is supported by our results on the oxygenation of
synthetic arachidonate derivatives by the wild-type rabbit
15-LOX and its 12-lipoxygenating mutants (I418A,
F353L).
15-LOXs are capable of catalysing 5-lipoxygenation of
substrates, which cannot be oxygenated at C15 because of
their structural properties. In these cases the substrate may
be aligned inversely at the active site and the energetic
barrier associated with burying the carboxylate in the hy-
drophobic active site is re£ected by a strongly reduced
binding a⁄nity [9,23]. The soybean LOX-1 converts 15S-
HPETE inter alia to the corresponding 5S,15S-diHPETE
but the KM for this reaction was some 20 times higher
Fig. 6. Oxygenation products formed from the monomethyl ester of 18-
HOOC-C19 :v5,8,11,14 by wild-type recombinant 5- and 15-LOXs. Wild-
type human 5- and rabbit 15-LOXs were expressed in E. coli. Aliquots
of the bacterial lysis supernatant exhibiting a comparable arachidonic
acid oxygenase activity were incubated in the standard assay systems
(optimal assay for each enzyme) for 5 min at room temperature. The
oxygenation products were reduced with sodium borohydride, the pro-
teins were precipitated with 1 ml ice-cold methanol and after centrifuga-
tion aliquots were injected to RP-HPLC using a solvent system of meth-
anol/water/acetic acid (70:30:0.1, v/v). Inset: Comparison of the
oxygenation rate of arachidonic acid and the dicarboxylic acid mono-
methyl ester. The rate of arachidonic acid oxygenation for each enzyme
was set at 100%. The product marked with an asterisk was identi¢ed by
MS as 5-hydroxylated free dicarboxylic acid. It was formed from the
corresponding monomethyl ester by unspeci¢c E. coli esterases, which
were co-puri¢ed with the 5-LOX.
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than for arachidonic acid oxygenation [23]. The rabbit 15-
LOX introduces molecular dioxygen predominantly at C5
of 15-HETE methyl ester and here again the KM is much
higher than that of arachidonic acid oxygenation [9]. The
data obtained in this study indicate for the ¢rst time that
under certain conditions 15-LOXs preferentially catalyse
5-lipoxygenation even though 15-lipoxygenation of the
substrate is theoretically possible. As a mechanistic reason
for this 5-lipoxygenation an inverse head-to-tail orienta-
tion of the substrate molecule was suggested (Scheme 2)
and our results obtained with the 12-lipoxygenating 15-
LOX mutant I418A (Table 5) support this hypothesis.
To force the inverse substrate orientation the fatty acids
must be modi¢ed simultaneously at both ends of the hy-
drocarbon chain. Introduction of a bulky or polar residue
at the methyl terminus was not su⁄cient and neither was
methylation of the carboxylate. However, if both types of
modi¢cation were carried out simultaneously an inverse
substrate alignment appeared to be favoured. With a de-
¢ned substrate there may be a binding equilibrium be-
tween arachidonic acid-like orientation (methyl terminus
slides into the binding pocket) and inverse substrate align-
ment (carboxylate group penetrates into the pocket). This
equilibrium appears to be in£uenced by functional groups
on either end of the fatty acid chain. Introduction of polar
or bulky residues [^OH, C-(CH3)3] at the g terminus is
expected to shift the binding equilibrium towards an in-
verse substrate orientation. However, since the energy bar-
rier associated with burying the polar carboxylate in the
hydrophobic substrate-binding pocket is rather high, such
an equilibrium shift may be prevented. When, in addition,
the hydrophobicity of the carboxylate is augmented by
methylation the energetic barrier is reduced and the bind-
ing equilibrium is shifted towards inverse substrate orien-
tation. The increased share of 5-lipoxygenation may indi-
cate this equilibrium shift. It is important to note that the
pattern of oxygenation products may not quantitatively
re£ect the binding equilibrium. In other words, a lack of
5-lipoxygenation products does not exclude an inverse
substrate binding. If, for instance, the inversely bound
substrate is not oxygenated because of steric constraints
(abortive substrate binding) an exclusive 15-lipoxygena-
tion may be observed despite the fact that a certain per-
centage of the substrate is inversely aligned.
In contrast to 15-LOXs for which many experimental
data are available on the substrate alignment, much less is
known for mammalian 5-LOXs. For the time being there
are two alternative hypotheses, which rationalise the
mechanistic basis for the positional speci¢city of 5-LOXs
[13,14]. The volume theory suggested that all LOX iso-
forms align the substrates at the active site in a similar
way irrespective of their positional speci¢city. The most
important factor in£uencing the speci¢city of LOX iso-
forms may be the volume of the substrate-binding pocket.
15-LOXs have a small cavity and thus, polyenoic fatty
acids are oxygenated close to the methyl terminus. In con-
trast, more space is available in the substrate-binding cleft
of 5-LOXs. In this case the fatty acid substrates may slide
farther into the cavity leading to an oxygenation close to
the carboxylate. Sequence-based structural modelling sug-
gested that the substrate-binding cavity of mammalian 5-
LOXs is some 20% larger than that of 15-LOXs [5,14].
The major disadvantage of the conserved orientation hy-
pothesis is that the stereochemistry of 5S-lipoxygenation is
not straightforward. However, given the conformational
£exibility of fatty acid derivatives it appears possible to
position the pro-S hydrogen at C7 close to the enzymes
hydrogen acceptor. According to the orientation hypoth-
esis [13,24] fatty acid substrates may slide into the active
site with its carboxylate ahead for 5-lipoxygenation so that
the bisallylic C7 is located close to the enzyme’s hydrogen
acceptor. This model easily explains the stereochemistry of
5-lipoxygenation. However, the major drawback of this
model is that an inverse substrate orientation may be pre-
vented by an energy barrier associated with burying the
polar carboxylate in the hydrophobic environment of the
active site. It should be stressed that for the time being
neither of the two hypotheses has been proven experimen-
tally. Since direct structural investigation of 5-LOX/sub-
strate interaction is not possible at the moment we ap-
proached the problem by a combination of targeted
substrate modi¢cation and site-directed mutagenesis. Tak-
en together our data suggest that 5-lipoxygenation by
mammalian 15-LOXs involves an inverse head-to-tail sub-
strate orientation. In contrast, 5-lipoxygenation catalysed
by the human 5-LOX may follow the volume hypothesis
and there are several lines of experimental evidence sup-
porting this conclusion. (i) A gradual decrease in the active
site volume induced by site-directed mutagenesis converted
the human 5-LOX to a 15-lipoxygenating enzyme species
(Fig. 5). (ii) The orientation hypothesis requires that 5-
LOXs can bury a free carboxylate at the active site. If
this is the case dicarboxylic fatty acids should be suitable
substrates for these enzymes. However, we found that the
dicarboxylic acid 18-HOOC-C19 :v5,8,11,14 was not oxy-
genated by the wild-type 5-LOX. (iii) The monomethyl
ester of the dicarboxylic fatty acid was oxygenated with
a high reaction rate and product analysis indicated major
5-lipoxygenation. If one assumes that the more hydropho-
bic methylcarboxylate slides into the substrate-binding
pocket the initial hydrogen removal takes place at a bisal-
lylic methylene which is far away from the methylated
carboxylate. A similar situation may be the case for ara-
chidonic acid. (iv) An inverse substrate orientation would
be favoured if a positively charged amino acid was present
at the bottom of the active site to interact with the sub-
strate’s carboxylate [20]. However, structural modelling
did not provide any evidence for a charged group at the
active site of the human 5-LOX [14]. If this is true, an
inverse orientation would be hindered by an energy bar-
rier, which should be re£ected by a strongly reduced sub-
strate a⁄nity. However, the oxygenation kinetics (KM and
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Vmax) of arachidonic acid by 5-LOXs are similar to those
of the 15-LOX reaction [25].
Summarising our data one may conclude that substrate
fatty acids may be oriented in either direction (straight or
inverse orientation) at the active site of LOXs. The chem-
ical structure of the substrate appears to be important for
its orientation and di¡erent LOX isoforms behave di¡er-
ently. Although there are no direct structural data avail-
able on enzyme/substrate complexes of any LOX isoform
structural modelling and our mutagenesis data suggest
a conserved substrate alignment for mammalian 15- and
5-LOXs. For other LOX isoforms, in particular for plant
enzymes [20], the situation may be di¡erent.
4. Signi¢cance
LOXs constitute a heterogeneous family of lipid-perox-
idising enzymes and the di¡erent mammalian LOX iso-
forms (15-LOXs, 12-LOXs, 8-LOXs and 5-LOXs) are cat-
egorised with respect to their positional speci¢city of
arachidonic acid oxygenation. They have been implicated
in physiological and pathophysiological events, such as
cell di¡erentiation, in£ammation, carcinogenesis and athe-
rosclerosis. For future investigations on the biological rele-
vance of these enzymes genetically modi¢ed cells (trans-
fectants) and organisms (transgenic animals and knockout
mice) as well as isoform-speci¢c inhibitors are needed. For
the rational design of isoform-speci¢c inhibitors detailed
knowledge of the structural di¡erences of the various iso-
forms and their catalytic peculiarities is required. It has
been suggested before that substrate alignment at the ac-
tive site is important for LOX speci¢city and for arachi-
donate 5-lipoxygenation two alternative hypotheses have
been introduced. The space-based hypothesis suggests that
the way of substrate binding is conserved among all LOX
isoforms and that fatty acids may slide into the substrate-
binding pocket with their g end ahead. According to the
orientation-based hypothesis fatty acid substrates may
slide into the substrate-binding cleft with their carboxylate
end ahead, and thus may be inversely aligned. We inves-
tigated the impact of targeted substrate modi¢cation and
site-directed mutagenesis on substrate alignment and con-
cluded that both hypotheses may be relevant. For 15-
LOX-catalysed 5-lipoxygenation substrate fatty acids ap-
pear to be inversely aligned. In contrast, for 5-LOX-cata-
lysed 5-lipoxygenation the space-related hypothesis may be
more suitable to explain the experimental data. It should
be stressed that ¢nal proof for either of the hypotheses can
only be provided by direct structural investigations of en-
zyme/substrate complexes. However, such experiments are
di⁄cult to perform since they have to be carried out under
strictly anaerobic conditions. Since such conditions can
hardly be achieved on earth experiments in orbit may be
helpful.
5. Materials and methods
5.1. Chemicals
The chemicals used were obtained from the following sources:
arachidonic acid (5Z,8Z,11Z,14Z-eicosatetraenoic acid), HPLC
standards of 5S-HETE, 12S-HETE, 15S-HETE and sodium bo-
rohydride from Serva (Heidelberg, Germany), ampicillin from
Gibco (Eggenstein, Germany), isopropyl-L-D-thiogalactopyrano-
side (IPTG) from Sigma-Aldrich (Deisenhofen, Germany). Re-
striction enzymes were purchased from New England Biolabs
(Schwalbach, Germany). Phage T4 ligase, Pwo polymerase and
sequencing kits were obtained from Boehringer Mannheim
(Mannheim, Germany). The E. coli strains HB 101 and M15 as
well as the pQE-9 expression plasmid were purchased from Invi-
trogen (San Diego, CA, USA). Oligonucleotide synthesis was
carried out by TiB-Molbiol (Berlin, Germany). All solvents
were of HPLC grade and purchased from Baker (Deventer, The
Netherlands). The polyenoic fatty acids used in this study were
synthesised as reported before [26,27].
5.2. Preparation of the native rabbit 15-LOX
The native reticulocyte-type 15-LOX was prepared from the
stroma-free haemolysis supernatant of a reticulocyte-rich blood
cell suspension [28] by ammonium sulphate precipitation, hydro-
phobic interaction chromatography and anion exchange chroma-
tography on a preparative Mono-Q column (Pharmacia, Upp-
sala, Sweden). The ¢nal enzyme preparation was
electrophoretically pure (6 95%) and exhibited a linoleic acid
turnover rate of about 30 s31.
5.3. Expression of the recombinant rabbit 15-LOX and enzyme
puri¢cation
For convenient puri¢cation of the recombinant rabbit reticulo-
cyte 15-LOX the enzyme was overexpressed as a His tag fusion
protein in E. coli. To clone the cDNA into the expression plasmid
a SalI site was introduced at the starting methionine by PCR
add-on mutation. The reverse PCR primer was placed in the
cDNA coding region behind a unique S¢I site. The PCR product
was digested with SalI and S¢I and puri¢ed by gel electrophore-
sis. This SalI/S¢I fragment was ligated together with the S¢I/
HindIII restriction fragment of the LOX cDNA into the pQE-9
expression vector, which was previously cleaved with SalI and
HindIII to yield the 15-LOXpQE-9 expression plasmid. This pro-
cedure led to modi¢cation of the enzyme’s N-terminus (Met-Arg-
Gly-(His)6-Gly-Ser-Val-Asp-LOX(Gly-Val-)), which did not in-
£uence the enzyme characteristics. The 15-LOXpQE-9 expression
plasmid was used to transform E. coli (M15 cells) and cells were
grown at 37‡C in 10 ml LB medium containing 100 Wg/ml ampi-
cillin and 25 Wg/ml kanamycin for 7 h. This culture was added to
400 ml of the same medium and grown at 37‡C overnight to an
approximate OD600 of 1. After addition of 1 mM IPTG, the
culture was incubated at 30‡C for 3 h and cells were pelleted
by centrifugation. The expressed recombinant proteins were pu-
ri¢ed on a Ni-column using the Bug Buster Ni-NTA His bind kit
from Novagen (Bad Soden, Germany). After cell lysis with the
Bug Buster protein extraction reagent the lysis supernatant was
incubated at 4‡C with 0.5 ml of Ni-agarose equilibrated with 0.1
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M phosphate bu¡er, pH 7.4 for 1 h in an overhead shaker. The
agarose was transferred to a polypropylene column, washed twice
with 4 ml washing bu¡er (10 mM imidazole, 500 mM NaCl, 20
mM Tris, pH 7.9) and the recombinant enzyme species were
eluted with 2 ml elution bu¡er (200 mM imidazole, 500 mM
NaCl, 20 mM Tris, pH 7.9).
To express the human 5-LOX as a non-fusion protein (the His
tag 5-LOX was catalytically inactive) its cDNA was subcloned
into the expression plasmid pKK 233-2 [9] and bacteria (HB 101)
were transformed with the recombinant plasmid. Bacteria were
grown overnight in 10 ml LB medium containing ampicillin (0.1
mg/l). 1 ml of this pre-culture was added to 200 ml LB medium
(0.1 mg/l ampicillin) and the bacteria were grown at 37‡C to an
optical density at 600 nm of 1.0. Expression of the recombinant
5-LOX species (wild-type or mutant) was then induced with 1 mM
IPTG and the culture was incubated for an additional 12 h at
30‡C. Cells were spun down, washed with phosphate-bu¡ered
saline, resuspended in 2 ml of 50 mM TRA/HCl bu¡er, pH 7.3
containing 2 mM EDTA and 10 mM mercaptoethanol. Cells
were lysed by sonication (three times for 20 s with a Labsonic
U-tip soni¢er), cell debris was removed by centrifugation and the
lysis supernatant was used as the enzyme source. In selected ex-
periments the recombinant enzyme species (wild-type and mu-
tants) were puri¢ed by a⁄nity chromatography on ATP Sephar-
ose [9].
Our puri¢cation strategy for the two recombinant enzyme spe-
cies and their mutants did not lead to electrophoretically homo-
geneous enzyme preparations, but all attempts of further puri¢-
cation were accompanied by severe losses in enzyme activity. In
order to avoid misinterpretations of the experimental data most
of the experiments were repeated with crude enzyme preparations
(bacterial lysis supernatant). In neither case did we observe sig-
ni¢cant di¡erences in the positional speci¢city of crude and pu-
ri¢ed enzyme preparations.
5.4. Site-directed mutagenesis
Site-directed mutagenesis of the LOX isoforms (I418A, F353L
for the rabbit 15-LOX; F359W+A424I+N425M+A603I for the
human 5-LOX) was carried out by the PCR-mediated overlap
extension technique using mismatching synthetic oligonucleo-
tides. The cDNA constructs were sequenced completely to verify
their primary structures. At least 10 LOX-positive clones were
assayed for their LOX activities and recombinants exhibiting
the highest activity were used for the experiments.
5.4.1. Assay system
The oxygenation kinetics of the di¡erent fatty acid derivatives
were assayed spectrophotometrically measuring the increase in
absorbance at 235 nm. The assay mixture, which consisted of
0.1 M phosphate bu¡er, pH 7.4 containing various concentra-
tions of substrate fatty acid, was sonicated in an ultrasonic
bath before the reaction was started by addition of enzyme. Mea-
surements were carried out at room temperature.
For analysis of the oxygenation products formed by the re-
combinant LOX species aliquots of partially puri¢ed enzyme
preparations were incubated with various substrates (0.1 mM
¢nal substrate concentration) at room temperature for 15 min.
For the 15-LOX and its mutants the assay mixture was 1 ml of
sodium/potassium phosphate bu¡er, pH 7.4 containing 0.1 mM
substrate fatty acid. The hydroperoxy fatty acids formed were
reduced to the corresponding hydroxy derivatives with sodium
borohydride. After acidi¢cation to pH 3 an equal volume of
methanol was added, protein precipitate was spun down and
aliquots were injected to RP- or SP-HPLC analysis. To analyse
the product pattern of the wild-type and mutant 5-LOX aliquots
of the bacterial lysis supernatant or of the puri¢ed enzyme prep-
aration were incubated in 1 ml Tris^HCl bu¡er, pH 7.4 contain-
ing 0.1 mM arachidonic acid, 0.4 mM CaCl2, 40 Wg/ml dipalmi-
toyl phosphatidylcholine and 0.1 mM ATP. After 15 min of
incubation the hydroperoxy compounds formed were reduced
with sodium borohydride to the corresponding hydroxy deriva-
tives, the mixture was acidi¢ed to pH 3 and 1 ml of ice-cold
methanol was added. The protein precipitate was spun down
and aliquots of the clear supernatant were injected to RP-
HPLC quanti¢cation of the LOX products.
5.4.2. Analytics
RP-HPLC was performed with a Shimadzu LC-6A liquid chro-
matograph connected to a Hewlett Packard diode array detector
1040A. Separation of the fatty acid derivatives was performed on
a Nucleosil C-18 column (Macherey-Nagel, Du«ren, Germany;
250U4 mm, 5 Wm particle size) and a guard column (30U4
mm, 5 mm particle size, same vendor). For analysis of mono-
hydroxylated fatty acids solvent systems consisting of methanol/
water/acetic acid (80:20:0.1 or 70:30:0.1, v/v) and a £ow rate of
1 ml/min were used. The absorbance at 235 nm was recorded. SP-
HPLC was performed on a Nucleosil 100-7 column (Macherey-
Nagel, Du«ren, Germany; 250U4 mm, 5 Wm particle size) with
the solvent system hexane/2-propanol/acetic acid and a £ow
rate of 1 ml/min. The 2-propanol content varied between
1 and 5% depending on the chemical structure of the substrate.
For quanti¢cation of the chromatograms a calibration curve
(¢ve-point measurement at di¡erent concentrations) was estab-
lished.
For GC/MS analysis the hydroxy fatty acids were prepared by
RP- and/or SP-HPLC, methylated with diazomethane and their
hydroxy groups were silylated with bis(trimethylsilyl)tri£uoroace-
tamide (Sigma Chemicals, Deisenhofen, Germany) in dry pyri-
dine. GC/MS was carried out on a Shimadzu GC-MS QP-2000
system equipped with a fused silica column SPB 1 (10 mU0.25
mm, coating thickness 0.25 Wm). An injector temperature of
270‡C, an ion source temperature of 180‡C and an electron en-
ergy of 70 eV were adjusted. The derivatised fatty acids were
eluted with the following temperature programme: from 130‡C
at a rate of 50‡C/min to 200‡C, then at a rate of 5‡C/min to
260‡C followed by an isothermal post-run of 10 min.
Negative ion mass spectrometry of the underivatised HPLC-
pure hydroxy fatty acids was performed with an LCQ ion trap
mass spectrometer (Thermoquest, Engelsbach, Germany) using
electrospray ionisation at 4 kV. The hydroxy fatty acids were
dissolved in a 1:1 mixture of 50 mM ammonium bicarbonate
bu¡er pH 8.0 and methanol. Aliquots were injected with a syringe
pump (3 Wl/min) into the injection capillary, which was heated to
200‡C. Molecular mass ions were detected in the range of m/z
100^500. Fragmentation of the selected molecular ions was car-
ried out with a voltage ranging between 10 and 40 V.
5.4.3. Miscellaneous methods
Protein concentration of the LOX preparations was determined
with the Bio-Rad kit. For more informative mass spectra the
methylated trimethylsilyl derivatives of the polyenoic fatty acids
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(10 Wg dissolved in 1 ml of ethanol) were hydrogenated using 5 mg
of palladium asbestos as the catalyst. Hydrogen gas was bubbled
through this mixture for 2 min at room temperature. The solution
was ¢ltered to remove the catalyst, the solvent was evaporated
and the residue was reconstituted in 20 Wl of dodecane. Aliquots
were injected to GC/MS as described above. It should be noted
that hydrogenation was carried out before silylating the OH
groups.
Acknowledgements
The authors wish to thank Mrs C. Gerth for technical
assistance and Dr K. Janek for carrying out electrospray
mass spectrometry. Financial support for this study was
provided by the Deutsche Forschungsgemeinschaft (Ku
961/7-1) and by the European Community (BMH4-
CT98-3191). Parts of this work were carried out during
a sabbatical of I.I. at the Humboldt University.
References
[1] A.R. Brash, Lipoxygenases : Occurrence, functions, catalysis and ac-
quisition of substrate, J. Biol. Chem. 274 (1999) 23679^23682.
[2] H. Kuhn, B.J. Thiele, The diversity of lipoxygenase family, FEBS
Lett. 449 (1999) 7^11.
[3] J.C. Boyington, B.J. Ga¡ney, L.M. Amzel, The three-dimensional
structure of an arachidonic acid 15-lipoxygenase, Science 260 (1993)
1482^1486.
[4] W. Minor, J. Steczko, B. Stec, Z. Otwinowski, J.T. Bolin, R. Walter,
B. Axelrod, Crystal structure of soybean lipoxygenase L-1 at 1.4 Aî
resolution, Biochemistry 35 (1996) 10687^10701.
[5] S.A. Gillmor, A. Villasenor, R. Fletterick, E. Sigal, M. Browner, The
structure of mammalian 15-lipoxygenase reveals similarity to the li-
pase and the determinants of substrate speci¢city, Nature Struct.
Biol. 4 (1997) 1003^1009.
[6] E. Skrzypczak-Jankun, L.M. Amzel, B.A. Kroa, M.O. Funk, Struc-
ture of soybean lipoxygenase L3 and comparison with its L1 isoen-
zyme, Proteins 29 (1997) 15^31.
[7] D.L. Sloane, R. Leung, C.S. Craik, E. Sigal, A primary determinant
for lipoxygenase positional speci¢city, Nature 354 (1991) 149^152.
[8] S. Borngra«ber, M. Browner, S. Gillmor, C. Gerth, M. Anton, R.
Fletterick, H. Ku«hn, Shape and speci¢city in mammalian 15-lipoxy-
genase active site, J. Biol. Chem. 274 (1999) 37345^37350.
[9] K. Schwarz, M. Walther, M. Anton, C. Gerth, I. Feussner, H. Kuhn,
Structural basis for lipoxygenase speci¢city, J. Biol. Chem. 276 (2001)
773^779.
[10] Q.F. Gan, M.F. Browner, D.L. Sloane, E. Sigal, De¢ning the ara-
chidonic acid binding site of human 15-lipoxygenase. Molecular mod-
eling and mutagenesis, J. Biol. Chem. 271 (1996) 25412^25418.
[11] M. Hamberg, B. Samuelsson, On the speci¢city of the oxygenation of
unsaturated fatty acids catalyzed by soybean lipoxidase, J. Biol.
Chem. 242 (1967) 5329^5335.
[12] H. Ku«hn, H. Sprecher, A.R. Brash, On singular or dual positional
speci¢city of lipoxygenases. The number of chiral products varies
with alignment of methylene groups at the active site of the enzyme,
J. Biol. Chem. 265 (1990) 16300^16305.
[13] S.T. Prigge, B.J. Ga¡ney, L.M. Amzel, Relation between positional
speci¢city and chirality in mammalian lipoxygenases, Nature Struct.
Biol. 5 (1998) 178^179.
[14] M. Browner, S.A. Gillmor, R. Fletterick, Burying a charge, Nature
Struct. Biol. 5 (1998) 179.
[15] M.R. Egmond, G.A. Veldink, J.F. Vliegenthart, J. Boldingh, C-11
H-abstraction from linoleic acid, the rate-limiting step in lipoxygen-
ase catalysis, Biochem. Biophys. Res. Commun. 54 (1973) 1178^1184.
[16] K. Schwarz, S. Borngra«ber, M. Anton, H. Kuhn, Probing the sub-
strate alignment at the active site of 15-lipoxygenases by targeted
substrate modi¢cation and site directed mutagenesis, Biochemistry
37 (1998) 15327^15335.
[17] M. Jisaka, R.B. Kim, W.E. Boeglin, A.R. Brash, Identi¢cation of
amino acid determinants of the positional speci¢city of mouse 8S-
lipoxygenase and human 15S-lipoxygenase-2, J. Biol. Chem. 275
(2000) 1287^1293.
[18] I. Ivanov, K. Schwarz, H.G. Holzhu«ttwer, G. Myagkova, H. Kuhn,
g-Oxidation impairs oxidizability of polyenoic fatty acids by 15-
lipoxygenases. Consequences for substrate orientation at the active
site, Biochem. J. 336 (1998) 345^352.
[19] R.W. Bryant, J.M. Bailey, T. Schewe, S.M. Rapoport, Positional
speci¢city of a reticulocyte lipoxygenase. Conversion of arachidonic
acid to 15-S-hydroperoxy-eicosatetraenoic acid, J. Biol. Chem. 257
(1982) 6050^6055.
[20] E. Hornung, M. Walther, H. Ku«hn, I. Feussner, Conversion of cu-
cumber linoleate 13-lipoxygenase to a 9-lipoxygenating species by
site-directed mutagenesis, Proc. Natl. Acad. Sci. USA 96 (1999)
4192^4197.
[21] W.D. Lehmann, Regio- and stereochemistry of the dioxygenation
reaction catalyzed by (S)-type lipoxygenases or by the cyclooxygenase
activity of prostaglandin H synthases, Free Radic. Biol. Med. 16
(1994) 241^253.
[22] H. Kuhn, T. Schewe, S.M. Rapoport, The stereochemistry of the
reactions of lipoxygenases and their metabolites. Proposed nomencla-
ture of lipoxygenases and related enzymes, Adv. Enzymol. Relat.
Areas Mol. Biol. 58 (1986) 273^311.
[23] C.P. van Os, G.P. Rijke-Schilder, H. van Halbeek, J. Verhagen, J.F.
Vliegenthart, Double dioxygenation of arachidonic acid by soybean
lipoxygenase-1. Kinetics and regio-stereo speci¢cities of the reaction
steps, Biochim. Biophys. Acta 663 (1981) 177^193.
[24] S.T. Prigge, J.C. Boyington, B.J. Ga¡ney, L.M. Amzel, Structure
conservation in lipoxygenases: structural analysis of soybean lipoxy-
genase-1 and modeling of human lipoxygenases, Proteins 24 (1996)
275^291.
[25] D. Aharony, R.L. Stein, Kinetic mechanism of guinea pig neutrophil
5-lipoxygenase, J. Biol. Chem. 261 (1986) 11512^11519.
[26] I.V. Ivanov, N.V. Groza, S.G. Romanov, H. Ku«hn, G.I. Myagkova,
18-Iodooctadeca-(8Z,11Z)-dienoic acid as useful intermediate for the
synthesis of special lipoxygenase substrates bearing bulky substituents
at the g-position, Tetrahedron 56 (2000) 335^336.
[27] I.V. Ivanov, N.V. Groza, S.G. Romanov, H. Ku«hn, G.I. Myagkova,
Total synthesis of the lipoxygenase substrate (5Z,8Z,11Z,14Z)-non-
adeca-5,8,11,14-tetra-1,19-dioic acid and (5Z,8Z,11Z,14Z)-20,20-di-
methylheneicosa-5,8,11,14-tetraenoic acid, Synthesis 5 (2000) 691^
694.
[28] S.M. Rapoport, T. Schewe, R. Wiesner, W. Halangk, P. Ludwig, M.
Janicke-Ho«hne, C. Tannert, C. Hiebsch, D. Klatt, The lipoxygenase
of reticulocytes. Puri¢cation, characterization and biological dynam-
ics of the lipoxygenase; its identity with the respiratory inhibitors of
the reticulocyte, Eur. J. Biochem. 96 (1979) 545^561.
CHBIOL 115 9-8-01
790 Chemistry & Biology 8/8 (2001) 779^790
